期刊文献+

抗磷脂抗体与儿童狼疮性肾炎 被引量:2

Antiphospholipid antibody and childhood lupus nephritis
下载PDF
导出
摘要 目的探讨儿童狼疮性肾炎(LN)抗磷脂抗体的阳性率及其与肾脏损害的临床表现/病理分型的关系。方法回顾性分析1997年—2009年确诊LN同时送检抗磷脂抗体的住院患儿的临床和病理资料。结果共50例患儿符合纳入标准,男11例、女39例,平均就诊年龄(11.8±2.1)岁。全部患儿均检测狼疮抗凝物(LA)和抗心磷脂抗体(aCL),31例检测抗β2糖蛋白I(β2-GPI)抗体,其中抗磷脂抗体阳性44例(88.0%),LA、aCL和抗β2-GPI抗体的阳性率分别为80.0%、52.0%和67.7%。抗磷脂抗体阳性与阴性的LN患儿相比,肾病水平蛋白尿、肉眼血尿、高血压和肾功能异常的差异无统计学意义(P均>0.05)。44例患儿进行了肾脏活检,抗磷脂抗体阳性和阴性LN患儿的病理分型差异无统计学意义(P=0.322),Ⅴ型LN仅见于抗磷脂抗体阳性的病例;肾小球微血栓的发生率为20.5%(9/44例),其中18.2%(8/44例)检测抗磷脂抗体阳性。抗磷脂抗体阳性患儿血小板减少的发生率为47.7%,阴性者33.3%(P=0.674)。3例患儿有肾外血栓形成,2例血栓形成在甲基泼尼松龙冲击、中心静脉置管之后,2例在抗磷脂抗体阳性8个月和2年8个月后形成血栓。结论儿童LN中抗磷脂抗体阳性率较高,抗磷脂抗体与LN患儿的临床表现和肾脏病理分型无关,抗磷脂抗体可能是导致肾小球微血栓的主要原因,激素(大剂量)和中心静脉置管是抗磷脂抗体阳性LN患儿形成血栓的可能诱因。 Objective To investigate the prevalence of antiphospholipid antibody(aPL)in childhood lupus nephritis(LN),and the relationship of aPL with clinicopathological characteristics of LN.Methods The results of aPL tested and pathological data examined were retrospectively analyzed in 50 hospitalized children with LN consisting of 11 boys and 39 girls during Aug.1997 to Dec.2009.Results The mean age of 50 children with LN was 11.8±2.1 years(range:6.0-16.3 yrs).All children were tested for lupus anticoagulant(LA)and anticardiolipin(aCL),and 31/50 cases(62%)tested for anti-β2 glycoprotein I(β2GPI)antibody.The positive rates of aPL,LA,aCL and anti-β2GPI antibody were 88.0%,80.0%,52.0% and 67.7%,respectively.No significant differences were found in the prevalence of nephrotic proteinuria,macroscopic hematuria,hypertension and renal failure between aPL-positive and aPL-negative group(P0.05 for all).Forty-four children underwent renal biopsy.There was no significant difference in the distribution of ISN/RPS classification between the aPL-positive and negative children(P=0.322).LN class Ⅴ were just found in aPL-positive children.Glomerular microthrombosis were found in 9 out of 44 cases with renal biopsy,mostly aPL-positive(8 cases).The incidence of thrombocytopenia was higher in aPL-positive children than that in aPL-negative children(47.7% vs.33.3%,P=0.674).Three children were complicated by thrombosis which occurred in two cases of them after the use of pulse methylprednisolone and central venous catheterization.The duration from the detection of positive aPL to the occurrence of thrombosis were 8 months and 32 months in two children,respectively.Conclusions There is a higher positive rate of aPL in childhood LN.No significant association is found between aPL and clinicopathological characteristics of LN.aPL is probably the major reason to induce glomerular microthrombosis.The pulse methylprednisolone and central venous catheterization can probably be the inducement of thrombosis.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2011年第3期235-239,共5页 Journal of Clinical Pediatrics
关键词 狼疮性肾炎 抗磷脂抗体 儿童 血栓 lupus nephritis antiphospholipid antibody children thrombosis
  • 相关文献

参考文献19

  • 1黄建萍.抗磷脂抗体和狼疮性肾炎[J].临床儿科杂志,2007,25(4):315-317. 被引量:7
  • 2Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies [J]. Clin Rheum Dis, 1985,11 (3) :591-609.
  • 3Hoctlberg MC. Updating the American College of Rheu- matology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum,1997,40(9): 1725.
  • 4滕庆,何晓琥,李彩凤.系统性红斑狼疮患儿血清抗β_2-糖蛋白Ⅰ抗体亚型与抗心磷脂抗体对比性分析[J].中国实用儿科杂志,2004,19(11):678-680. 被引量:6
  • 5Avcin T, Benseler SM, Tyrrell PN, et al. A follow up sttMy of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus [J]. Arthritis Rheum, 2008.59(2) :206-213.
  • 6Descloux E, Durieu I, Cochat P, et al. Paediatric systemic lupus erythematosus: prognostic impact of anti- phospholipid antibodies [J]. Rheumatology (Oxford), 2008, 47(2) : 183-187.
  • 7Tsuruta Y, Uchida K, Itabashi M, et al. Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis [J]. Intern Med,2009,48(21 ) : 1875-1880.
  • 8Moroni G, Ventura D, Riva P, et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupusnephritis [J]. Am J Kidney Dis,2004,43( 1 ):28-36.
  • 9中华医学会儿科学分会肾脏病学组.狼疮性肾炎的诊断与治疗(草案)[J].中国实用儿科杂志,2003,18(3):190-190. 被引量:8
  • 10顾越英,叶霜.狼疮肾炎病理分型新进展的启示[J].中华风湿病学杂志,2004,8(9):513-514. 被引量:31

二级参考文献32

  • 1肖慧捷,杨霁云,高天霁,黄建萍,姚勇,张焱.儿童抗磷脂抗体阳性13例报告[J].中华儿科杂志,2004,42(8):571-573. 被引量:5
  • 2鲍春德,陈晓翔.抗磷脂综合征诊治进展[J].医师进修杂志,2004,27(12):4-7. 被引量:16
  • 3高瑞通,孙阳,郑法雷.抗磷脂综合征的肾损害[J].中华肾脏病杂志,2005,21(6):320-323. 被引量:12
  • 4Glassock RJ. Reclassification of lupus glomerulonephritis: back to the future. J Am Soc Nephrol, 2004, 15: 501-503.
  • 5Pollak VE, Pirani CL, Schwartz FD. The natural history of the reual manifestations of systemic lupus erythematosus. J Lab Clin Med, 1964, 63: 537-550.
  • 6Chan TM, Li FK, Tang CSO, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. New Engl J Med, 2000, 343: 1156-1162.
  • 7Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. New Engl J Med, 2004,350: 971-980.
  • 8Weening JJ, D′Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited.Kidney International, 2004, 65: 521-530.
  • 9Austin HA Ⅲ, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. New Engl J Med, 1986, 314: 614-619.
  • 10Balow JE, Austin HA Ⅲ Maintenance therapy for lupus nephritis: something old, something new. New Engl J Med, 2004,350:1044-1046.

共引文献48

同被引文献35

  • 1曾清华,郑秀娟,温振科,徐林,于宁,徐薇,储以微,熊思东.一株抗双链DNA单克隆抗体的制备及其特性研究[J].现代免疫学,2007,27(3):193-197. 被引量:2
  • 2Fmtos MA,Praga M,Quereda C,et al.Lupus nephriffs:in search of a better future[J].Nefmlogia,2012,32(2):136-138.
  • 3Heidenreich U,Mayer G,Herold M,et al.Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis[J].Lupus,2009,18(14):1276-1280.
  • 4Hartung K,seelig HP.Laboratory diagnostics of systemic autoimmune diseases[J].Z Rheumatol,2006,65(8):709-724.
  • 5Peterson LK,Wells D,Shaw L,et al.Novel method for quantitative ANA measurement using nearinfrared imaging[J].J Immunol Methods,2009,349(1/2):1-8.
  • 6Riboldi P,Gerosa M,Moroni G,et al.Anti-DNA antibodies:a diagnostic agnostic and prognostic tool for systemic lupus erythematosus[J].Autoimmunity,2005,38(1):39.
  • 7Pedchenko V,Bondar O,Fogo AB,et al.Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis[J].N Engl J Med,2010,363(3):343-354.
  • 8Rutgers A,Heeringa P,Damoiseaux JE,et al.ANCA and anti-GBM antibodies in diagnasis and follow-up of vasculitic disease[J].Eur J Intem Med,2003,14(2):287-295.
  • 9Yu F,Tan Y.Clinicopathological characteristics and outcomes of patients with crescentic lubus nephritis[J].Kidney Int,2009,76(3):307-317.
  • 10Sangle SR,Jan W,Lau IS,et al.Coeliac artery stenusis and antiphospholipid(Hughes)syndrome/antiphospholipid antibodies[J].Clin Exp Rheunatol,2006,24(3):349.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部